1. Home
  2. GOCO vs GANX Comparison

GOCO vs GANX Comparison

Compare GOCO & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOCO
  • GANX
  • Stock Information
  • Founded
  • GOCO 2001
  • GANX 2017
  • Country
  • GOCO United States
  • GANX United States
  • Employees
  • GOCO N/A
  • GANX N/A
  • Industry
  • GOCO Specialty Insurers
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOCO Finance
  • GANX Health Care
  • Exchange
  • GOCO Nasdaq
  • GANX Nasdaq
  • Market Cap
  • GOCO 64.9M
  • GANX 53.4M
  • IPO Year
  • GOCO 2020
  • GANX 2021
  • Fundamental
  • Price
  • GOCO $5.53
  • GANX $1.69
  • Analyst Decision
  • GOCO Hold
  • GANX Strong Buy
  • Analyst Count
  • GOCO 1
  • GANX 5
  • Target Price
  • GOCO $18.00
  • GANX $8.00
  • AVG Volume (30 Days)
  • GOCO 48.1K
  • GANX 328.9K
  • Earning Date
  • GOCO 08-07-2025
  • GANX 08-12-2025
  • Dividend Yield
  • GOCO N/A
  • GANX N/A
  • EPS Growth
  • GOCO N/A
  • GANX N/A
  • EPS
  • GOCO N/A
  • GANX N/A
  • Revenue
  • GOCO $822,444,000.00
  • GANX N/A
  • Revenue This Year
  • GOCO $8.51
  • GANX N/A
  • Revenue Next Year
  • GOCO $7.19
  • GANX N/A
  • P/E Ratio
  • GOCO N/A
  • GANX N/A
  • Revenue Growth
  • GOCO 17.46
  • GANX N/A
  • 52 Week Low
  • GOCO $5.01
  • GANX $0.95
  • 52 Week High
  • GOCO $21.00
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • GOCO 45.74
  • GANX 54.36
  • Support Level
  • GOCO $5.53
  • GANX $1.45
  • Resistance Level
  • GOCO $6.11
  • GANX $2.12
  • Average True Range (ATR)
  • GOCO 0.40
  • GANX 0.16
  • MACD
  • GOCO -0.01
  • GANX 0.03
  • Stochastic Oscillator
  • GOCO 15.93
  • GANX 39.44

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: